Showing results (671-680 of 9,900) with videos related to
Sort By:
Pageof 990
Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.Bone Marrow Transplantation|July 14, 2015
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2F V Michelis, H A Messner, E G Atenafu, et al.Bone Marrow Transplantation|June 2, 2015
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipientsB K Hamilton, A D Law, L Rybicki, et al.Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.Bone Marrow Transplantation|July 7, 2015
Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective studyM Detrait, S Morisset, Y Chalandon, et al.Bone Marrow Transplantation|July 19, 2016
The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine modelT Ikezoe, J Yang, C Nishioka, et al.Bone Marrow Transplantation|July 19, 2016
Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantationK B Ehrlich, G E Miller, T Scheide, et al.Bone Marrow Transplantation|July 19, 2016
YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndromeB Kornblit, T Wang, S J Lee, et al.Bone Marrow Transplantation|April 15, 2020
Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV statusRaphael Carapito, Ismail Aouadi, Angélique Pichot, et al.Bone Marrow Transplantation|April 15, 2020
Precision medicine: Statistical methods for estimating adaptive treatment strategiesErica E M Moodie, Elizabeth F KrakowPageof 990